ANGO Financial Facts

General and administrative: 7.32M
Research and development: 6.72M
See Full Income Statement

Additional paid-in capital: 510.7M
Accounts payable: 29.28M
See Full Balance Sheet

AngioDynamics (ANGO) Earnings

  |   Expand Research on ANGO
Next EPS Date 4/9/15 EPS Growth Rate 0.0%
Average EPS % Beat Rate +46.6% Revenue Growth Rate +1.8%
Average % Move 1-Wk after EPS -2.7% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/9/15 Q315 N/A$0.16 N/A N/A$89.8M N/A N/A
1/8/15 Q215 $0.17$0.15 +$0.02$92.1M$90.9M Details
10/9/14 Q115 $0.16$0.11 +$0.05$87.3M$85.3M Details
7/23/14 Q414 $0.18$0.12 +$0.06$94.1M$93.65M Details
4/9/14 Q314 $0.16$0.09 +$0.07$88.2M$86.85M N/A Details
1/9/14 Q214 $0.14$0.07 +$0.07$88.6M$87.54M N/A Details
10/10/13 Q114 $0.04$0.03 +$0.01$83.6M$82.54M Details
7/11/13 Q413 $0.07$0.06 +$0.01$90M$86.43M N/A Details